Work

Abstract 962: Identification of a PFKFB3 inhibitor suitable for phase I trial testing that synergizes with the B-Raf inhibitor vemurafenib

Year: 2014

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2014-962

Authors: Julie O'Neal, Gilles Tapolsky, Brian Clem, Sucheta Telang, Jason Chesney

Institutions: University of Louisville, Advanced Cancer Therapeutics

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1559416338

Cites:

Cited by: 3

Related to: 10